Advertisement

Nuvera Biosciences, a cancer diagnostics company, announced positive results for a breast cancer test that is designed to predict which patients may be cured by chemotherapy. The Woburn-based company says the test, which has now been studied in two large trials, can help guide treatment for newly diagnosed patients.

Company officials say currently, determining which patients will respond best to chemotherapy versus other treatment options – including experimental therapies – is a challenge.

SOURCE

Advertisement
Advertisement